Automated Analyzers Market Report 2024

This Automated Analyzers market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The automated analyzers market size has grown strongly in recent years. It will grow from $4.68 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historical period is driven by greater awareness of preventive healthcare, an expanding elderly population, increased demand for non-invasive diagnostic tests, as well as the expansion of clinical research and drug development activities.

The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $6.64 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth projected for the forecast period is expected to be fueled by the expansion of veterinary diagnostics, a stronger emphasis on reducing diagnostic errors and improving patient outcomes, along with the rise of telemedicine and remote monitoring. Key trends include the emergence of novel biomarkers, point-of-care diagnostics, home-based devices, miniaturization of diagnostic tools, and advancements in multi-analyte testing platforms.

The automated analyzers market is expected to grow as chronic diseases become more common. The increase in chronic conditions is driven by aging populations, unhealthy lifestyles, and global urbanization. Automated analyzers play a crucial role in managing these diseases by providing efficient and precise diagnostic testing, which helps in early detection, monitoring, and treatment of illnesses such as diabetes, cardiovascular diseases, and kidney disorders. For example, a report from Kidney Research UK in June 2023 highlighted that around 7.2 million people in the UK have chronic kidney disease, making up over 10% of the population. Among these, 3.25 million are in advanced stages, while 3.9 million are in the early stages. It is anticipated that by 2033, the number of people with chronic kidney disease will reach 7.61 million. This increasing prevalence of chronic diseases is driving the growth of the automated analyzers market.

Key players in the automated analyzers market are concentrating on creating advanced solutions such as automated clinical chemistry analyzers to improve efficiency, accuracy, and throughput in diagnostic labs. These analyzers are sophisticated instruments designed for performing a variety of chemical tests on blood and other bodily fluids with minimal human involvement, thereby enhancing diagnostic precision and efficiency. For instance, in January 2024, Beckman Coulter, a US-based company, introduced the DxC 500 AU Chemistry Analyzer. This state-of-the-art device features over 120 high-quality assays and aims to significantly improve the capabilities of satellite and independent community hospital labs. It offers advanced automation, streamlined workflows, and standardized reagents to enhance testing efficiency and support clinical decision-making. The DxC 500 AU serves as a crucial addition to central hub laboratories within healthcare systems using hub-and-spoke models, improving overall efficiency and access to essential testing services.

In April 2024, Valmet, a technology company based in Finland, acquired Siemens Healthineers AG’s process gas chromatography business for $113.05 million. This acquisition is part of Valmet’s strategy to strengthen its automation segment and enhance its process automation capabilities, particularly in gas chromatograph and process analyzer systems. The acquired business will be integrated into Valmet’s automation systems division under a new unit, analyzer products, and integration, thereby solidifying Valmet’s position in this sector. Siemens Healthineers AG, a German company specializing in automated analyzers, is the company from which this business was acquired.

Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson, and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc.

North America was the largest region in the automated analyzers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automated analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Automated analyzers are lab devices built to conduct repetitive analytical tests with minimal human involvement. They boost efficiency by processing large sample volumes swiftly and accurately. These systems are widely employed in clinical, chemical, and hematological analyses.

The primary types of automated analyzers include biochemistry, immuno-based, hematology analyzers, and more. Biochemistry analyzers are lab tools used to determine the concentration of various biochemical substances in biological samples for both diagnostic and research purposes. They process samples such as blood, urine, serum, plasma, and others. These analyzers are applied in fields such as drug discovery, genomics, proteomics, bioanalysis, and clinical diagnostics, serving end users such as hospitals, diagnostic labs, pharmaceutical and biotech companies, among others.

The automated analyzers market research report is one of a series of new reports that provides automated analyzers market statistics, including the automated analyzers industry's global market size, regional shares, competitors with an automated analyzers market share, detailed automated analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the automated analyzers industry. This automated analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The automated analyzers market consists of sales of biochemistry analyzers, hematology analyzers, immunoassay analyzers, blood gas analyzers, and molecular analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.